CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $275,000 | -12.4% | 517,806 | +800.7% | 0.04% | 0.0% |
| Q4 2019 | $314,000 | +307.8% | 57,488 | +265.2% | 0.04% | +270.0% |
| Q3 2019 | $77,000 | -40.3% | 15,742 | -7.9% | 0.01% | +42.9% |
| Q3 2018 | $129,000 | -81.7% | 17,100 | -87.7% | 0.01% | -80.0% |
| Q2 2018 | $704,000 | +49.2% | 139,500 | +109.8% | 0.04% | +20.7% |
| Q4 2017 | $472,000 | -34.5% | 66,500 | -34.0% | 0.03% | -40.8% |
| Q3 2017 | $721,000 | +94.9% | 100,800 | +71.4% | 0.05% | +104.2% |
| Q2 2017 | $370,000 | – | 58,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |